Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$662M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$116M |
| 3 |
Broadcom
AVGO
|
+$96.2M |
| 4 |
Walmart Inc
WMT
|
+$91.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$175M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$152M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$149M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 4.33% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Vir Biotechnology
VIR
$1.68B
| $443K | ﹤0.01% |
+68,349
| New | +$608K |
|
2352
Flex
FLEX
$39.4B
| $442K | ﹤0.01% |
13,366
-297
| -2% | -$11.6K |
|
2353
PUT
Zimmer Biomet
ZBH
$19.3B
| $441K | ﹤0.01% |
3,900
+1,800
| +86% | +$193K |
|
2354
CALL
Middleby
MIDD
$5.21B
| $441K | ﹤0.01% |
+2,900
| New | +$455K |
|
2355
M/I Homes
MHO
$3.84B
| $440K | ﹤0.01% |
3,856
-14,569
| -79% | -$1.79M |
|
2356
CALL
Motorola Solutions
MSI
$79.7B
| $438K | ﹤0.01% |
1,000
-8,300
| -89% | -$3.7M |
|
2357
PUT
Applied Optoelectronics
AAOI
$9.14B
| $436K | ﹤0.01% |
28,400
-11,500
| -29% | -$289K |
|
2358
CALL
Carlyle Group
CG
$17.5B
| $436K | ﹤0.01% |
10,000
-400
| -4% | -$19.8K |
|
|
CADE
2359
DELISTED
Cadence Bank
CADE
| $436K | ﹤0.01% |
+14,352
| New | +$476K |
|
2360
PUT
Jabil
JBL
$31.9B
| $435K | ﹤0.01% |
+3,200
| New | +$492K |
|
2361
PUT
US Bancorp
USB
$97.3B
| $435K | ﹤0.01% |
+10,300
| New | +$475K |
|
|
PGRE
2362
DELISTED
Paramount Group
PGRE
| $434K | ﹤0.01% |
101,022
+31,028
| +44% | +$140K |
|
2363
PUT
Olin
OLN
$2B
| $434K | ﹤0.01% |
17,900
+7,200
| +67% | +$203K |
|
|
GTLS
2364
PUT
DELISTED
Chart Industries
GTLS
| $433K | ﹤0.01% |
+3,000
| New | +$552K |
|
2365
CALL
Louisiana-Pacific
LPX
$5.08B
| $432K | ﹤0.01% |
4,700
-6,600
| -58% | -$689K |
|
2366
CALL
CRISPR Therapeutics
CRSP
$5.52B
| $432K | ﹤0.01% |
+12,700
| New | +$538K |
|
2367
XPeng
XPEV
$10.7B
| $431K | ﹤0.01% |
+20,823
| New | +$375K |
|
2368
CALL
Intercontinental Exchange
ICE
$91.5B
| $431K | ﹤0.01% |
2,500
+1,100
| +79% | +$180K |
|
2369
Plexus
PLXS
$6.33B
| $431K | ﹤0.01% |
3,361
-28,826
| -90% | -$4.05M |
|
2370
Accenture
ACN
$114B
| $429K | ﹤0.01% |
+1,375
| New | +$486K |
|
2371
CALL
Public Service Enterprise Group
PEG
$36.6B
| $428K | ﹤0.01% |
5,200
-32,500
| -86% | -$2.71M |
|
2372
iShares MSCI United Kingdom ETF
EWU
$3.85B
| $426K | ﹤0.01% |
+11,365
| New | +$411K |
|
2373
CALL
Rambus
RMBS
$9.44B
| $425K | ﹤0.01% |
8,200
-8,400
| -51% | -$493K |
|
2374
Hartford Financial Services
HIG
$37.6B
| $423K | ﹤0.01% |
3,418
-23,785
| -87% | -$2.73M |
|
|
SF
2375
Stifel
SF
$12.2B
| $422K | ﹤0.01% |
6,714
+1,854
| +38% | +$131K |
|
Similar funds
Paul Tudor Jones's Q1 2025 Portfolio in Review
As of Q1 2025, Paul Tudor Jones held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Paul Tudor Jones deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.
- Paul Tudor Jones's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
- Paul Tudor Jones added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
- Paul Tudor Jones's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
- Paul Tudor Jones fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
- Paul Tudor Jones's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
- Paul Tudor Jones opened 874 new positions and closed 844 in Q1 2025.
- Paul Tudor Jones's portfolio value rose 15% quarter-over-quarter to $30.1B.
Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.